货号：UP152821954
| 产品信息 | |
| 产品名称： | Clazosentan |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 180384-56-9 |
| 分子式： | C25H23N9O6S |
| 分子量： | 577.57 |
| MDL NO： | MFCD20040418 |
| 标准纯度： | 98+% (UP152821954) |
| 沸点： | - |
| 储存： | (UP152821954) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
GHSR
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
CRF receptor
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
Glucagon Receptor
(E)-1-Methyl-4-(2-nitrovinyl)benzene
UP5546856855153-68-4
2-(Phenylethynyl)benzaldehyde
UP80858480759046-72-9
N'-Hydroxy-5-methylpyrazine-2-carboximidamide
UP833640332832113-99-2
Methyl 4-hydroxy-3-methoxybenzoate
UP6775840803943-74-6
1-Isocyanato-3-methylbenzene
UP129787116621-29-4
a-D-Mannose pentaacetate
UP8796966374163-65-9
BAY 41-2272
UP171247189256376-24-6
2-Fluorobenzohydrazide
UP689609996446-24-2
Diethyl benzylphosphonate
UP8593860311080-32-6
2-Methoxybenzenesulfonyl chloride
UP81949693110130-87-7
CCT137690
UP3297521241095382-05-0
Raltegravir Potassium
UP892246893871038-72-1
(E)-3-(4-Chlorophenyl)acrylaldehyde
UP51851293849678-02-6
1-(Difluoromethyl)-4-nitro-1H-pyrazole
UP264515221956477-64-8
TY-52156
UP953099735934369-14-9
N-Hydroxycyclopropanecarboximidamide
UP17041635651285-13-3
(E)-(2-Nitrovinyl)benzene
UP7442208375153-67-3
MK-3697
UP1412659781224846-01-8
Pasireotide L-aspartate
UP694227217396091-77-3
CP-466722
UP2330950611080622-86-1
NPS-2143 hydrochloride
UP957840686324523-20-8
Dibenzo[b,d]thiophene 5-oxide
UP5913200801013-23-6
4-(4-Hydroxyphenyl)cyclohexanone
UP617792599105640-07-1
Ethyl 2-cyanopropanoate
UP8495018571572-99-2
Atrasentan
UP929841041173937-91-2
S-(((1S,2S)-1-(Cyanomethyl)-2-fluorocyclopropyl)methyl) ethanethioate
UP133121448N/A
2-(Phenylmethylene)butanedioic acid
UP1812630605653-88-3
Diethyl succinate
UP971169414123-25-1
Prasugrel Maleic acid
UP771996044389574-20-3
Isobutyramide
UP140452699563-83-7
(E)-6-Bromo-3-(6-bromo-2-oxoindolin-3-ylidene)indolin-2-one
UP7801395361351240-72-6
NU-7199
UP82613812069541-04-4
JNJ-7706621
UP884018001443797-96-4
N1,N1,N2,N2-Tetramethyldiazene-1,2-dicarboxamide
UP96295411010465-78-8
1-N-Boc-2-Methyl-Isothiourea
UP293516711173998-77-1
AZD1152-HQPA
UP932380616722544-51-6
2-Iodobenzaldehyde
UP43819522926260-02-6
(E)-Ethyl 2-cyano-3-ethoxyacrylate
UP67643319242466-67-1
2-(Trifluoromethyl)phenyl carbonochloridate
UP722445260869676-40-4
Compound 401
UP354549706168425-64-7
1-Phenylcyclobutanecarbonyl chloride
UP2873471074620-67-1
VE-821
UP7221184811232410-49-9
2,6-Difluorobenzene-1-sulfonyl chloride
UP16889249760230-36-6
BQ-788
UP627161098173326-37-9
2-(2-Bromoethyl)thiophene
UP46665501826478-16-0
PF-06380101
UP2841062041436391-86-4
(4-(Chloromethyl)phenyl)(phenyl)sulfane
UP8817845191208-87-3
(E)-3-(3-Bromo-4-fluorophenyl)acryloyl chloride
UP881564930676348-50-8
CGK733
UP707498514905973-89-9
HJC0350
UP445082080885434-70-8
Sitagliptin
UP694270381486460-32-6
Clazosentan
UP152821954180384-56-9